Literature DB >> 23248851

[Genetic diversity of group A rotavirus isolates found in Western Siberia in 2007-2011].

E V Zhirakovskaia, R Kh Aksanova, M G Gorbunova, A Iu Tikunov, A M Kuril'shchikov, S N Sokolov, S V Netesov, N V Tikunova.   

Abstract

Genetic analysis of group A rotavirus recovered from fecal samples of children admitted to hospitals in Novosibirsk and Omsk during four epidemic seasons 2007, 2007/2008, 2009/2010, 2010/2011 was performed. A total of 1416 rotavirus isolates were genotyped using multiplex PCR. The isolates of the most common rotavirus genotypes G1P[8], G4P[8], G2P[4], G3P[8] co-circulated in Western Siberia during 2007-2011. In isolated cases G9P[8], G2P[8], G3P[9], and G4P[6] genotypes were detected. Change of dominant genotype from G1P[8] to G4P[8] occurred in 2008 in Omsk and in Novosibirsk in 2009 as well. Incidence and distribution of rotavirus genotypes differed and changed every epidemic season in both cities. The phylogenetic analysis based on VP4 (VP8*), VP7, and VP6 gene sequences showed that the majority of isolates from Novosibirsk and Omsk were clustered together and demonstrated high level homology with rotavirus isolates found in other regions of Eurasia. In addition, a rare P[8]b (OP354-like) subtype of the VP4 gene was identified in fourteen isolates (G9, G1, and G4) in Novosibirsk and in a single isolate Omsk08-381/G9P[8]b in Omsk. The results obtained in this study demonstrate the necessity of long-term monitoring of rotavirus isolates in Western Siberia. This is important for selection of rotavirus vaccine for immunization of infants, improvement of diagnostic kits and understanding of the epidemiology and the evolution of group A rotaviruses.

Entities:  

Mesh:

Year:  2012        PMID: 23248851

Source DB:  PubMed          Journal:  Mol Gen Mikrobiol Virusol        ISSN: 0208-0613


  5 in total

1.  Molecular-Genetic Characterization of Human Rotavirus A Strains Circulating in Moscow, Russia (2009-2014).

Authors:  Victoria Kiseleva; Evgeny Faizuloev; Elena Meskina; Anna Marova; Alexey Oksanich; Tatiana Samartseva; Georgy Bakhtoyarov; Natalia Bochkareva; Nikolay Filatov; Andrey Linok; Yulia Ammour; Vitaly Zverev
Journal:  Virol Sin       Date:  2018-07-30       Impact factor: 4.327

2.  Emerging OP354-Like P[8] Rotaviruses Have Rapidly Dispersed from Asia to Other Continents.

Authors:  Mark Zeller; Elisabeth Heylen; Susan Damanka; Corinna Pietsch; Celeste Donato; Tsutomu Tamura; Ruta Kulkarni; Ritu Arora; Nigel Cunliffe; Leena Maunula; Christiaan Potgieter; Sana Tamim; Sarah De Coster; Elena Zhirakovskaya; Salwa Bdour; Helen O'Shea; Carl D Kirkwood; Mapaseka Seheri; Martin Monene Nyaga; Jeffrey Mphahlele; Shobha D Chitambar; Ron Dagan; George Armah; Nina Tikunova; Marc Van Ranst; Jelle Matthijnssens
Journal:  Mol Biol Evol       Date:  2015-04-08       Impact factor: 16.240

Review 3.  Review of global rotavirus strain prevalence data from six years post vaccine licensure surveillance: is there evidence of strain selection from vaccine pressure?

Authors:  Renáta Dóró; Brigitta László; Vito Martella; Eyal Leshem; Jon Gentsch; Umesh Parashar; Krisztián Bányai
Journal:  Infect Genet Evol       Date:  2014-09-16       Impact factor: 3.342

4.  Whole Genomic Analysis of Human G12P[6] and G12P[8] Rotavirus Strains that Have Emerged in Myanmar.

Authors:  Tomihiko Ide; Satoshi Komoto; Kyoko Higo-Moriguchi; Khaing Win Htun; Yi Yi Myint; Theingi Win Myat; Kyaw Zin Thant; Hlaing Myat Thu; Mo Mo Win; Htun Naing Oo; Than Htut; Mitsutaka Wakuda; Francis Ekow Dennis; Kei Haga; Yoshiki Fujii; Kazuhiko Katayama; Shofiqur Rahman; Sa Van Nguyen; Kouji Umeda; Keiji Oguma; Takao Tsuji; Koki Taniguchi
Journal:  PLoS One       Date:  2015-05-04       Impact factor: 3.240

5.  Emergence of human G2P[4] rotaviruses containing animal derived gene segments in the post-vaccine era.

Authors:  Mark Zeller; Valerie Nuyts; Elisabeth Heylen; Sarah De Coster; Nádia Conceição-Neto; Marc Van Ranst; Jelle Matthijnssens
Journal:  Sci Rep       Date:  2016-11-14       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.